From start-up to Hong Kong IPO: How global standards drove this S’pore biomedical firm’s expansion
Singapore biotechnology company Mirxes started life in a research lab, running on notebooks and Excel sheets. Bringing a cancer-detection blood test to market meant leaving all of that behind. “We went from lab notebooks and Excel sheets to documented and …